{"disease":{"id":"facial-rejuvenation","name":"facial rejuvenation"},"drugs":{"marketed":[{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Fibroblasts for the Treatment of Aesthetic Facial Rejuvenation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Stromal Vascular Fraction for the Treatment of Aesthetic Facial Rejuvenation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07160777","title":"Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Semikal Technology","has_results":false},{"nct_id":"NCT04643977","title":"Assessment of the Safety and Efficacy of the Dermal Filler \"mARG-01-17\" in Facial Rejuvenation Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mesoestetic Pharma Group S.L.","has_results":false},{"nct_id":"NCT03537456","title":"Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation","phase":"NA","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Mesoestetic Pharma Group S.L.","has_results":false},{"nct_id":"NCT02730650","title":"Platelet Rich Therapy for Facial Rejuvenation","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT07227883","title":"Secretome Treatment for Facial Rejuvenation","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Acorn Biolabs Inc.","has_results":false},{"nct_id":"NCT03962621","title":"A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"xjpfW","has_results":false},{"nct_id":"NCT02551562","title":"A Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"DeNova Research","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}